Cookie Policy

Terms of Use Privacy Policy Cookie Policy
Report an adverse event Swiss Professional Information Swiss Patient Information

IMPRESSUM
This website was created by Incyte

Incyte Biosciences International Sàrl
Rue Dr Yersin 12
CH-1110 Morges
Switzerland

Oncology.CH@incyte.com
+41 21 581 50 00

Marketing authorisation holder:
Incyte Biosciences International Sàrl, Morges

Healthcare professionals are required to report any suspected new or serious side effects. See the “Undesirable effects” section of the Swiss Professional Information for the terms and conditions for reporting side effects.

Adverse events should also be reported to Incyte immediately by phoning 00800 000 274 23 or via email at eumedinfo@incyte.com.

Incyte

CH/PEMA/P/24/0002
Date of preparation: April 2024
This website is created and funded by Incyte
© 2024, Incyte. All rights reserved.
PEMAZYRE, the PEMAZYRE logo and the Incyte logo are registered trademarks of Incyte

If you would like to request further medical information, please visit:
https://www.incyteglobalmedicalinformation.com/

External link disclaimer

Intended for licensed healthcare professionals located in Switzerland.

You are now leaving the Incyte PEMAZYRE website. This link will take you to a site that is not owned or maintained by Incyte. Incyte is not responsible for the information contained on third⁠–⁠party sites. Would you like to continue?

Yes No

Report an adverse event